PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25304479-3	2014	Furthermore, because of evidence indicating that midazolam has equal potency at the benzodiazepine site on the GABAA receptor and the 18-kd translocator protein (TSPO), it is possible that at least the nerve-blocking actions of midazolam are mediated by this alternative site of action.	Midazolam	228-237	translocator protein	Rattus norvegicus	162-166	
25304479-9	2014	CONCLUSIONS: Our results indicate that processes underlying midazolam-induced nerve block and neurotoxicity are separable, and suggest that selective activation of TSPO may facilitate modality-selective nerve block while minimizing the potential for neurotoxicity.	Midazolam	60-69	translocator protein	Rattus norvegicus	164-168	
24988461-3	2014	Midazolam, a ligand for TSPO and central benzodiazepine receptor (CBR), induces anxiolytic- and anti-depressant-like effects in animal models.	Midazolam	0-9	translocator protein	Rattus norvegicus	24-28	
24988461-16	2014	In summary, this study demonstrated that midazolam improves the behavioral deficits in the SPS model through dual TSPO and CBR and neurosteroidogenesis.	Midazolam	41-50	translocator protein	Rattus norvegicus	114-118